Virologists reveal how poor man’s amino acid cure for COVID-19 would abolish need for vaccines
Bio-Virus Research Inc (Nevada), September 15, 2021
A natural cure for COVID-19 that is widely available and affordable for even the poorest of people on the planet has been confirmed by a team of virologists who have spent a lifetime studying the underlying causes of viral infections.
Backed by decades of research and safety data for herpes-family viruses, U.S.-based researchers at Bio-Virus Research Inc, Reno, Nevada, report on the successful treatment of the first 30 frontline doctors and nurses and a thousand-plus patients given the amino acid lysine to prevent and even abolish COVID-19 coronavirus infections at a clinic in the Dominican Republic. Astonishingly, symptoms of COVID-19 are reported to have dissipated within hours of this natural treatment.
The medical staff at a clinic in the Dominican Republic was coming down with two cases of coronavirus per month before lysine therapy was instituted.
The virologists, Drs. Christopher Kagan, Bo Karlicki and Alexander Chaihorsky, strongly suggested the front-line healthcare workers embark on a daily regimen of lysine therapy due to daily exposure to the virus. Their ground-breaking report is published online at ResearchGate.net.
Lysine therapy interrupts the replication of viruses, including COVID-19 coronavirus, by countering arginine, an amino acid that fosters the eruption of dormant viruses. Lysine has been safely used for decades to quell herpes virus outbreaks that cause cold sores on the lips (herpes labialis), a treatment pioneered by one of the Bio-Virus Research team members in 1974.
Lysine is available in foods and in concentrated form in inexpensive dietary supplements (250 500-milligram lysine tablets can be purchased for under $5 US or 2-cents per tablet), making affordable lysine therapy possible.
Lysine/arginine imbalance would explain why patients who have been infected with COVID-19 have recurrent infections, even after vaccination.
Lysine Rx in Dominican Republic
The daily therapeutic supplement regimen for the medical staff in the Dominican Republic consisted of 2000 milligrams of lysine capsules along with restricted dietary consumption of arginine-rich foods such as nuts, chocolate, orange juice, pumpkin, sesame seeds, wheat germ.
The Bio-Virus Research team found doses of supplemental lysine up to 4000 milligrams to be safe and effective.
Foods that have a high ratio of lysine over arginine such as eggs, tofu, fish (not raw), sardines, cheese, meats such as pork, poultry and red meat, and yogurt) provide a high ratio of lysine over arginine, thus blocking replication of all coronaviruses including COVID-19.
According to the virologists who were interviewed by this reporter, over 1000 patients have now been successfully treated with surprisingly rapid dissolution of symptoms and return to health. Even severely infected COVID-19 patients have been able to come off the ventilator with lysine therapy, say doctors.
Third-party validation for lysine therapy
Writing in the International Journal of Infectious Diseases another research team based in New York and Texas reports that arginine depletion is a strategy to quell both coronaviruses and other herpes family viruses.
The Bio-Virus Research team are not loners nor out on a scientific limb. A report, published in the Journal of Antivirals & Antiretrovirals, is what prompted to the current discovery that was put into clinical practice in the Dominican Republic. The science was in place prior to the announcement a mutated coronavirus was sweeping the globe which no one had immunity towards.
The Recommended Daily dietary intake of lysine is 2660 milligrams for a 154-lb (70 kilogram) adult; 3640 milligrams during pregnancy.
Dietary intake of lysine in western populations ranges from 40-180 milligrams per day per kilogram (2.2 lbs.) of body weight, or 2800-12,600 milligrams for a 154 lb. (70 kilogram) adult.
It is the balance of arginine to lysine that controls the eruption of dormant viruses in the body. The average intake of arginine is estimated to be 4000-6000 milligrams per day.
Other health benefits
Supplemental lysine also has other health benefits. Lysine increases absorption of calcium, relieves bouts of anxiety, promotes wound healing, and is helpful for other conditions. Cholesterol is deposited in binding sites within coronary arteries. When lysine (and vitamin C) occupy those binding sites, cholesterol is not deposited in arteries.
Prevalence of herpes viral infections
Worldwide many billions of people harbor dormant herpes viruses that erupt into disease from time to time. In 2016 an estimated 3.7 billion people had herpes simplex virus infection– around 66.6% of the world’s population aged 0 to 49.
Availability of lysine
Lysine is largely produced by the tons for animal feedstuffs. Roughly 2,200,000 tons of lysine are produced annually. There is no shortage.
Billions may benefit
The most frequent medical application of lysine therapy has been the quelling of active herpes infections (on skin, lips, etc.), and eradication of Epstein-Barr infection, Bell’s palsy, etc.
Researchers bemoan the fact that lysine therapy hasn’t become a mainstay in the treatment of herpes infections that affect ~80% of the world’s population over expensive and problematic anti-viral drugs because it doesn’t generate sufficient profit to attract funding for human clinical trials. Lysine is superior to various anti-viral drugs.
If lysine lives up to its promise as a universal COVID-19 antidote for therapeutic and preventive use, unless billionaire Bill Gates buys up and mothballs all the lysine production plants in the world like he has bought off agricultural land, and bought off news media, vaccine makers and politicians, the need for vaccines will become a moot and meaningless practice for COVID-19.
Because of the long-term safety record of this dietary amino acid, the public can take lysine as a non-prescription preventive “medicine.”
Epidemiologists baffled by low rate of coronavirus infections in India
Despite its large population and poor sanitation, disease trackers are baffled by India’s low rate of coronavirus infections. Maybe it is India’s lysine-rich diet of yogurt, lamb, chicken, fish curry that protects its population from viral disease. The striking difference in the country-to-country prevalence of Herpes Simplex-2 infections (only 9.6% in South East Asian countries and 10.7% in Europe vs. 24.0% in the Americas and 43.9% in Africa) could be explained by the lysine/arginine ratio in native diets.
Treat the severely ill; skip the problematic vaccines
Vaccination is not fool proof. Vaccinated patients are testing positive for COVID-19. Doctors can choose to treat the 3 in 10,000 COVID-19 severely infected patients who are at risk for a mortal outcome with lysine rather than needlessly vaccinate billions of people. Mass vaccination would not be needed, nor would lockdowns, quarantines and questionable mass face mask use be required. The pandemic would be rapidly extinguished by a public information campaign regarding lysine-rich foods and dietary supplements. The public can take action on its own today without adverse consequences. Literally, trillions of dollars would be saved worldwide. If not for COVID-19, at least for herpes infections.
The shame is on the World Health Organization with a budget of $8.482 billion or the Centers For Disease Control with a budget of $7.875 billion that overlook safe and economical cures like lysine. This report serves as evidence the world is being gamed to plunder the masses of their health and wealth. The people of the world need to stop heeding advice from public health officials and practice preventive medicine on their own volition.
There is additional evidence that lysine also halts the growth of influenza and coxsackie viruses.
Researchers at Bio-Virus Research Inc. are searching for research funds to further document the benefits of lysine therapy.
Omega-3 and Omega-6 supplement improves reading for children
University of Gothenburg, Sweden - September 14, 2021
Supplement of omega-3 and omega-6 fatty acids may improve reading skills of mainstream schoolchildren, according to a new study from Sahlgrenska Academy, at the University of Gothenburg, Sweden. Children with attention problems, in particular, may be helped in their reading with the addition of these fatty acids.
The study included 154 schoolchildren from western Sweden in grade 3, between nine and ten years old. The children took a computer-based test (known as the Logos test) that measured their reading skills in a variety of ways, including reading speed, ability to read nonsense words and vocabulary.
The children were randomly assigned to receive either capsules with omega-3 and omega-6, or identical capsules that contained a placebo (palm oil) for 3 months. The children, parents and researchers did not learn until the study was completed which children had received fatty acids and which had received the placebo. After three months, all children received real omega-3/6 capsules for the final three months of the study.
"Even after three months, we could see that the children's reading skills improved with the addition of fatty acids, compared with those who received the placebo. This was particularly evident in the ability to read a nonsense word aloud and pronounce it correctly (phonologic decoding), and the ability to read a series of letters quickly (visual analysis time)," says Mats Johnson, who is chief physician and researcher at the Gillberg Neuropsychiatry Centre at Sahlgrenska Academy, University of Gothenburg.
No children diagnosed with ADHD were included in the study, but with the help of the children's parents, the researchers could identify children who had milder attention problems. These children attained even greater improvements in several tests, including faster reading already after three months of receiving fatty acid supplements.
Polyunsaturated fats and their role in children's learning and behavior is a growing research area.
"Our modern diet contains relatively little omega-3, which it is believed to have a negative effect on our children when it comes to learning, literacy and attention," says Mats Johnson. "The cell membranes in the brain are largely made up of polyunsaturated fats, and there are studies that indicate that fatty acids are important for signal transmission between nerve cells and the regulation of signaling systems in the brain."
Previous studies in which researchers examined the effect of omega-3 as a supplement for mainstream schoolchildren have not shown positive results, something Mats Johnson believes may depend on how these studies were organized and what combination and doses of fatty acids were used. This is the first double-blind, placebo-controlled study showing that omega-3/6 improves reading among mainstream schoolchildren.
"Our study suggests that children could benefit from a dietary supplement with a special formula. To be more certain about the results, they should also be replicated in other studies," says Mats Johnson.
The article Omega 3/6 fatty acids for reading in children: a randomized, double-blind, placebo-controlled trial in 9-year-old mainstream schoolchildren in Sweden was published by The Journal of Child Psychology and Psychiatry.
Elevated stress hormones linked to higher risk of high blood pressure and heart events
Kyoto University (Japan) & University of California at Los Angeles, Sept. 13, 2021
Adults with normal blood pressure and high levels of stress hormones were more likely to develop high blood pressure and experience cardiovascular events compared to those who had lower stress hormone levels, according to new research published today in Hypertension, an American Heart Association journal.
Studies have shown that cumulative exposure to daily stressors and exposure to traumatic stress can increase cardiovascular disease risk. A growing body of research refers to the mind-heart-body connection, which suggests a person’s mind can positively or negatively affect cardiovascular health, cardiovascular risk factors and risk for cardiovascular disease events, as well as cardiovascular prognosis over time.
“The stress hormones norepinephrine, epinephrine, dopamine and cortisol can increase with stress from life events, work, relationships, finances and more. And we confirmed that stress is a key factor contributing to the risk of hypertension and cardiovascular events,” said study author Kosuke Inoue, M.D., Ph.D., assistant professor of social epidemiology at Kyoto University in Kyoto, Japan. Inoue also is affiliated with the department of epidemiology at the Fielding School of Public Health at the University of California, Los Angeles.
“Previous research focused on the relationship between stress hormone levels and hypertension or cardiovascular events in patients with existing hypertension. However, studies looking at adults without hypertension were lacking,” Inoue said. “It is important to examine the impact of stress on adults in the general population because it provides new information about whether routine measurement of stress hormones needs to be considered to prevent hypertension and CVD events.”
Study subjects were part of the MESA Stress 1 study, a substudy of the Multi-Ethnic Study of Atherosclerosis (MESA), a large study of atherosclerosis risk factors among more than 6,000 men and women from six U.S. communities. As part of MESA exams 3 and 4 (conducted between July 2004 and October 2006), white, Black and Hispanic participants with normal blood pressure from the New York and Los Angeles sites were invited to participate in the substudy MESA Stress 1. In this substudy, researchers analyzed levels of norepinephrine, epinephrine, dopamine and cortisol – hormones that respond to stress levels. Hormone levels were measured in a 12-hour overnight urine test. The substudy included 412 adults ages 48 to 87 years. About half were female, 54% were Hispanic, 22% were Black and 24% were white.
Participants were followed for three more visits (between September 2005 and June 2018) for development of hypertension and cardiovascular events such as chest pain, the need for an artery-opening procedure, or having a heart attack or stroke.
Norepinephrine, epinephrine and dopamine are molecules known as catecholamines that maintain stability throughout the autonomic nervous system—the system that regulates involuntary body functions such as heart rate, blood pressure and breathing. Cortisol is a steroid hormone released when one experiences stress and is regulated by the hypothalamic-pituitary-adrenal axis, which modulates stress response.
“Although all of these hormones are produced in the adrenal gland, they have different roles and mechanisms to influence the cardiovascular system, so it is important to study their relationship with hypertension and cardiovascular events, individually,” Inoue said.
Their analysis of the relationship between stress hormones and development of atherosclerosis found:
- Over a median of 6.5-year follow-up period, every time the levels of the four stress hormones doubled was associated with a 21-31% increase in the risk of developing hypertension.
- During a median of 11.2-years of follow-up, there was a 90% increased risk of cardiovascular events with each doubling of cortisol levels. There was no association between cardiovascular events and catecholamines.
“It is challenging to study psychosocial stress since it is personal, and its impact varies for each individual. In this research, we used a noninvasive measure — a single urine test — to determine whether such stress might help identify people in need of additional screening to prevent hypertension and possibly cardiovascular events,” Inoue said.
"The next key research question is whether and in which populations increased testing of stress hormones could be helpful. Currently, these hormones are measured only when hypertension with an underlying cause or other related diseases are suspected. However, if additional screening could help prevent hypertension and cardiovascular events, we may want to measure these hormone levels more frequently.”
A limitation of the study is that it did not include people who had hypertension at the study’s start, which would have resulted in a larger study population. Another limitation is that researchers measured stress hormones via a urine test only, and no other tests for stress hormone measurement were used.
Spirulina alleviates high fat diet-induced cognitive impairment via the gut-brain axis
Weifang People’s Hospital (China), September 9, 2021
Increasing evidence suggested that the gut microbiome-brain axis plays a critical role in regulating cognitive functions. In this study, we aimed to investigate the dietary treatment effect of Spirulina platensis on learning deficits in high fat diet (HFD) fed mice and clarify the potential mechanisms via investigating the gut microbiome-brain axis. Dietary administration of 1% and 2% Spirulina platensis for 16 weeks significantly improved the spatial learning and memory performance of the HFD-fed mice in both Barnes Maze test and Morris water maze test. The Aβ accumulation, tau-hyperphosphorylation, and neuroinflammation in the hippocampus were significantly inhibited by Spirulina platensis. Spirulina platensis also abrogated HFD induced gut microbial dysbiosis and unbalance of gut microbial metabolites indicating its modulating effect on the gut-brain axis. This study provides further evidence for the application of Spirulina platensis as functional supplement for treatment of Alzheimer’s disease.
Spirulina platensis was frequently used as both a food ingredient and a medical supplement to counteract various metabolic disorders worldwide. In the present study, we found that Spirulina platensis dietary supplementation significantly prevented the cognitive deficits induced by HFD- feeding in mice. For the first time, we identified the inhibition effect of Spirulina platensis on β-amyloid generation, tau-hyperphosphorylation, neuroinflammation, and the gut microbiota dysbiosis.
In conclusion, the present study proved the beneficial effect of Spirulina platensis on cognitive impairment in HDF-fed AD mice and cleared Aβ, inhibited tau-hyperphosphorylation, and ameliorated neuroinflammation in the brain. Spirulina platensis also abrogated HFD induced gut microbial dysbiosis and unbalance of gut microbial metabolites indicating that Spirulina platensis might ameliorated cognitive deficits through regulating the gut-brain axis (Fig. 6). This study provides potent evidence for the application of Spirulina platensis as functional supplement for treatment of AD.
Regular exercise may lower risk of developing anxiety by almost 60%
University of Lund (Sweden), September 13, 2021
A quick online search for ways to improve our mental health will often come up with a myriad of different results. However, one of the most common suggestions put forward as a step to achieving wellness—and preventing future issues—is doing some physical exercise, whether it be a walk or playing a team sport.
Anxiety disorders—which typically develop early in a person's life—are estimated to affect approximately 10% of the world's population and has been found to be twice as common in women compared to men. And while exercise is put forward as a promising strategy for the treatment of anxiety, little is known about the impact of exercise dose, intensity or physical fitness level on the risk of developing anxiety disorders.
To help answer this question, researchers in Sweden have published a study in Frontiers in Psychiatry to show that those who took part in the world's largest long-distance cross-country ski race (Vasaloppet) between 1989 and 2010 had a "significantly lower risk" of developing anxiety compared to non-skiers during the same period.
The study is based on data from almost 400,000 people in one of the largest ever population-wide epidemiology studies across both sexes.
Surprising finding among female skiers
"We found that the group with a more physically active lifestyle had an almost 60% lower risk of developing anxiety disorders over a follow-up period of up to 21 years," said first author of the paper, Martine Svensson, and her colleague and principal investigator, Tomas Deierborg, of the Department of Experimental Medical Science at Lund University, Sweden.
"This association between a physically active lifestyle and a lower risk of anxiety was seen in both men and women."
However, the authors found a noticeable difference in exercise performance level and the risk of developing anxiety between male and female skiers.
While a male skier's physical performance did not appear to affect the risk of developing anxiety, the highest performing group of female skiers had almost the double risk of developing anxiety disorders compared to the group which was physically active at a lower performance level.
"Importantly," they said, "the total risk of getting anxiety among high-performing women was still lower compared to the more physically inactive women in the general population".
These findings cover relatively uncharted territory for scientific research, according to the researchers, as most previous studies focused on depression or mental illness as opposed to specifically diagnosed anxiety disorders. Furthermore, some of the largest studies looking at this topic only included men, were much smaller in sample size, and had either limited or no follow-up data to track the long-term effects of physical activity on mental health.
Next steps for research
The surprising discovery of an association between physical performance and the risk for anxiety disorders in women also emphasized the scientific importance of these findings for follow-up research.
"Our results suggest that the relation between symptoms of anxiety and exercise behavior may not be linear," Svensson said.
"Exercise behaviors and anxiety symptoms are likely to be affected by genetics, psychological factors, and personality traits, confounders that were not possible to investigate in our cohort. Studies investigating the driving factors behind these differences between men and women when it comes to extreme exercise behaviors and how it affects the development of anxiety are needed."
They added that randomized intervention trials, as well as long-term objective measurements of physical activity in prospective studies, are also needed to assess the validity and causality of the association they reported. But does this mean that skiing in particular can play an important role in keeping anxiety at bay, as opposed to any other form of exercise? Not so, Svensson and Deierborg said, given that previous studies have also shown the benefits of keeping fit on our mental health.
"We think this cohort of cross-country skiers is a good proxy for an active lifestyle, but there could also be a component of being more outdoors among skiers," they said.
"Studies focusing on specific sports may find slightly different results and magnitudes of the associations, but this is most likely due to other important factors that affect mental health and which you cannot easily control in research analysis.
Gut microbes are key to health benefit delivered by hops compound
Oregon State University, September 13, 2021
The health-enhancing performance of a compound found in hops is dependent upon its interactions with intestinal microorganisms, new research by Oregon State University shows.
Understanding how xanthohumol, often abbreviated as XN, works is important for unlocking its potential to counter diet-induced obesity and the health risksassociated with a global obesity epidemic, including type 2 diabetes and liver and heart disease, researcher Adrian Gombart says.
"We showed that the gut microbiota are necessary for the beneficial effects of XN on glucose metabolism," said Gombart, professor of biochemistry and biophysics in the OSU College of Science and a principal investigator at the university's Linus Pauling Institute. "There is an important interaction between the compound and the microbes in the gut that provides the benefits we see in our studies with mice."
Gombart led a team of 20 scientists from three Oregon State colleges in research that compared the glucose metabolism effects of xanthohumol on two sets of mice: "conventional" ones with gut microbiota, and those engineered to be "germ free," i.e. have no gut microbes.
Glucose metabolism, the body's ability to convert the sugar into fuel, generally suffers impairment as someone becomes obese, which in turn can lead to the person becoming more overweight. Faulty glucose metabolism also negatively affects brain physiology and is at the root of multiple medical conditions including diabetes and heart disease.
In previous studies involving mice, Gombart and colleagues found that XN improved the animals' health and changed the composition of their microbiome, the latter leading them to suspect that the mix of microbes played a role in XN's healthful effects.
"In this study, we fed mice either a diet low in calories, high in calories, or high in calories but supplemented with XN for 10 weeks," he said. "We found that only the conventional mice with XN supplementation showed improved glucose metabolism and that XN increased the relative abundance of three bacteria, Akkermansia muciniphila, Parabacteroides goldsteinii and Alistipes finegoldii."
Gombart added that the study yielded some evidence that those three microbes are at least partially responsible for the health benefits associated with XN, but the entire microbial community may be playing a role as well.
"We can't rule that out," he said. "We know that XN needs the intestinal microbiota to deliver its benefits, and there are complex diet-host-microbiota interactions that bring changes in both microbial composition and functional capacity. Diet is recognized as a major force in shaping gut microbe composition, and future studies will look for insights into the various interactions at play."
Earlier mouse model studies by co-author Fred Stevens, professor of pharmaceutical sciences in the OSU College of Pharmacy and also a principal investigator at the Linus Pauling Institute , have shown that XN, a polyphenol found in hops' cones, has a number of anti-obesity properties. It improves cognitive function and it suppresses weight gain associated with a high-fat diet, fat accumulation in adipose tissue and insulin resistance.
Insulin resistance is when cells don't respond well to the hormone that allows for the uptake of glucose from the bloodstream. It causes the pancreas to make more and more insulin to keep blood glucose levels within a non-harmful range and is a risk factor for non-alcoholic fatty liver disease.
Antioxidant protects neurons
University of Edinburgh September 12 2021
Research involving a potent antioxidant, described in Scientific Reports, suggests that the compound could help protect cells in several conditions, including Parkinson’s disease, multiple sclerosisand cell transplants.
In their report, a team from the University of Edinburgh observe that the flavonoids quercetin and myricetin are among the most potent dietary antioxidants. Structural modification of myricetin has resulted in the development a new compound known as Proxison. In the current research, Proxison demonstrated 10 times the ability to protect against oxidative stress induced by the compound tert-Butyl hydroperoxide (tBHP) in neuroblastoma cells compared to quercetin, while several other antioxidants showed no effects. Proxison, as well as a high concentration of quercetin, also provided significant protection against cell death in tBHP-treated cells. Similar results were obtained in another neural cell line.
An investigation of the antioxidants’ ability to be taken up by the cells showed significant intracellular levels of quercetin and Proxison, and evidence for some localization of Proxison in the cells’ mitochondria.
In zebrafish embryos, Proxison helped protect against neuronal cell loss induced by a neurotoxic compound. Quercetin was also protective, but was less potent than Proxison. Neither therapy affected normal embryonic development.
“This novel antioxidant can be applied to investigate oxidative stress in disease models, like alpha-synucleinopathies and other neurodegeneration models,” Nicola J. Drummond and colleagues conclude. “In addition, Proxison could have applications for regenerative medicine where oxidative stress has been implicated in poor cell survival of transplanted cells, with the advantage that the molecule can be pre-loaded into cells prior to transplantation. Proxison could also have applications for conditions, such as stroke or cardiac infarction, in which a temporary, but acute, exposure to oxidative stress is experienced, as well as diseases in which oxidative stress and mitochondrial dysfunction are core features.”